Type 1 and Type 2 Diabetic-Erectile Dysfunction: Same Diagnosis (ICD-9), Different Disease?

被引:42
作者
Chitaley, Kanchan [1 ]
机构
[1] Univ Washington, Dept Urol, Seattle, WA 98109 USA
关键词
Diabetes; Erectile Dysfunction; Type; 1; 2; NITRIC-OXIDE SYNTHASE; ENDOTHELIAL GROWTH-FACTOR; CORPUS CAVERNOSUM; IN-VIVO; PENILE ERECTION; RHOA/RHO-KINASE; GENE-THERAPY; DB/DB MOUSE; RAT MODEL; MELLITUS;
D O I
10.1111/j.1743-6109.2008.01183.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
100201 [内科学]; 100221 [泌尿外科学];
摘要
Introduction. Although hyperglycemia is a common defining feature of both type 1 and type 2 diabetes, many unique characteristics distinguish these diseases, including insulin and lipid levels, obesity status, and inflammatory agent profiles. In the laboratory, the presence of erectile dysfunction (ED) has been established in animal models of both type 1 and type 2 diabetes. Aim. The purpose of this study was to determine whether unique mechanisms underlie ED in type 1 vs. type 2 diabetic animal models. Main Outcome Measures. Many mechanisms can underlie ED, including impaired dilatory signaling, heightened contractile sensitivity, and verso-occlusive disorder. Methods. Using PubMed, the literature was mined to evaluate what is known about which mechanism underlie ED in type 1 vs. type 2 diabetic animal models. Results. Impaired cavernosal vasodilation has been established in type 1 diabetic rodents. This dysfunction appears to be mediated by a severe defect in non-adrenergic-non-cholinergic nerve signaling, as well as impairment in penile endothelial function. In contrast, type 2 diabetic animals appear to have minimal impairment in parasympathetic-mediated dilatory function, but do have evidence of endothelial dysfunction. Type 2 diabetic models also exhibit a significant and striking increase in cavernosal contractile sensitivity, and a significant verso-occlusive disorder, neither of which is consistently reported in type 1 diabetic animals. Conclusions. With the distinct mechanisms underlying the ED phenotype in animal models of type 1 and type 2 diabetes, tailoring therapeutic treatments for diabetic-ED to the specific mechanisms underlying this disease complication may be warranted. Further examination of mechanisms underlying ED in diabetic human patients may thus lead to significant changes in the way urologists diagnose, code, and treat diabetic-ED. Chitaley K. Type 1 and type 2 diabetic-erectile dysfunction: Same diagnosis (ICD-9), different disease? J Sex Med 2009;6(suppl 3):262-268.
引用
收藏
页码:262 / 268
页数:7
相关论文
共 41 条
[1]
Prevalence and risk factors for erectile dysfunction in Korean men: Results of an epidemiological study [J].
Ahn, Tai Young ;
Park, Jong Kwan ;
Lee, Sung Won ;
Hong, Jun Hyuk ;
Park, Nam Cheol ;
Kim, Je Jong ;
Park, Kwangsung ;
Park, Hyesook ;
Hyun, Jae Seog .
JOURNAL OF SEXUAL MEDICINE, 2007, 4 (05) :1269-1276
[2]
Endothelial nitric oxide synthase protein expression, localization, and activity in the penis of the alloxan-induced diabetic rat [J].
Akingba, AG ;
Burnett, AL .
MOLECULAR UROLOGY, 2001, 5 (04) :189-197
[4]
New treatment options for erectile dysfunction in patients with diabetes mellitus [J].
Basu, A ;
Ryder, REJ .
DRUGS, 2004, 64 (23) :2667-2688
[5]
Superoxide anion production in the rat penis impairs erectile function in diabetes: Influence of in vivo extracellular superoxide dismutase gene therapy [J].
Bivalacqua, TJ ;
Usta, MF ;
Kendirci, M ;
Pradhan, L ;
Alvarez, X ;
Champion, HC ;
Kadowitz, PJ ;
Hellstrom, WJG .
JOURNAL OF SEXUAL MEDICINE, 2005, 2 (02) :187-197
[6]
RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for diabetes-associated erectile dysfunction [J].
Bivalacqua, TJ ;
Champion, HC ;
Usta, MF ;
Cellek, S ;
Chitaley, K ;
Webb, RC ;
Lewis, RL ;
Mills, TM ;
Hellstrom, WJG ;
Kadowitz, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (24) :9121-9126
[7]
Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats [J].
Bivalacqua, TJ ;
Usta, MF ;
Champion, HC ;
Adams, D ;
McNamara, DB ;
Abdel-Mageed, AB ;
Kadowitz, PJ ;
Hellstrom, WJG .
JOURNAL OF UROLOGY, 2003, 169 (05) :1911-1917
[8]
Dysregulation of cGMP-dependent protein kinase 1 (PKG-1) impairs erectile function in diabetic rats:: influence of in vivo gene therapy of PKG1α [J].
Bivalacqua, Trinity J. ;
Kendirci, Muammer ;
Champion, Hunter C. ;
Hellstrom, Wayne J. G. ;
Andersson, Karl-Erik ;
Hedlund, Petter .
BJU INTERNATIONAL, 2007, 99 (06) :1488-1494
[9]
Urologic complications of diabetes [J].
Brown, JS ;
Wessells, H ;
Chancellor, MB ;
Howards, SS ;
Stamm, WE ;
Stapleton, AE ;
Steers, WD ;
Van Den Eeden, SK ;
McVary, KT .
DIABETES CARE, 2005, 28 (01) :177-185
[10]
Novel nitric oxide signaling mechanisms regulate the erectile response [J].
Burnett, AL .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2004, 16 (Suppl 1) :S15-S19